Neurogene Inc. – Underwriting Agreements

NASDAQ: NGNE
Share price (3/27/26): $20.35
Market cap (3/27/26): $317 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from SCHEDULE 13G ~1 page Joint Filing Agreement

from SCHEDULE 13G/A 1 page Joint Filing Agreement

from 10-Q 40 pages Neurogene Inc. Shares of Common Stock ($0.000001 Par Value Per Share) Sales Agreement

from 8-K 29 pages Neoleukin Therapeutics, Inc. Common Stock ($0.000001 Par Value) Atm Equity Offeringsm Sales Agreement

from 8-K 35 pages 3,262,471 Shares of Common Stock and Pre-Funded Warrants to Purchase 1,737,529 Shares of Common Stock Neoleukin Therapeutics, Inc. Underwriting Agreement July 1, 2020

from 8-K 38 pages 8,925,000 Shares of Common Stock Neoleukin Therapeutics, Inc. Underwriting Agreement December 17, 2019

from 8-K 38 pages 5,350,000 Shares Aquinox Pharmaceuticals, Inc. Common Stock, Par Value $0.000001 Per Share Underwriting Agreement September 19, 2016

from 8-K 39 pages 5,500,000 Shares Aquinox Pharmaceuticals, Inc. Common Stock, Par Value $0.000001 Per Share Underwriting Agreement September 9, 2015

from 8-K 32 pages Aquinox Pharmaceuticals, Inc. $25,000,000 Sales Agreement

from S-1/A 45 pages [—] Shares Aquinox Pharmaceuticals, Inc. Underwriting Agreement